Laboratory Testing

About

Information for

Programs

Publications

Regulations

Partners

Accreditations

  • Centers for Medicare & Medicaid Services
    CLIA Certificate of Compliance for High Complexity Clinical Laboratory
  • EPA Environmental Protection Agency
    Ambient Air and Drinking Water Testing
  • Food Science Laboratories are accredited by ANAB to ISO/IEC 17025:2017 for Testing Laboratories, Certificate AT-2054
  • Forensic Biology/DNA, Toxicology and Drug Chemistry Laboratories are accredited by ANAB to ISO/IEC 17025:2017 for Testing Laboratories, Certificate FT-0004, Federal Bureau of Investigations DNA Analysis & CODIS
  • Rhode Island Department of Health - In-State Analytical Laboratory Certificate
  • Rhode Island Department of Health - In-State Clinical Laboratory License

About

Information for

Programs

Publications

Regulations

Partners

Accreditations

  • Centers for Medicare & Medicaid Services
    CLIA Certificate of Compliance for High Complexity Clinical Laboratory
  • EPA Environmental Protection Agency
    Ambient Air and Drinking Water Testing
  • Food Science Laboratories are accredited by ANAB to ISO/IEC 17025:2017 for Testing Laboratories, Certificate AT-2054
  • Forensic Biology/DNA, Toxicology and Drug Chemistry Laboratories are accredited by ANAB to ISO/IEC 17025:2017 for Testing Laboratories, Certificate FT-0004, Federal Bureau of Investigations DNA Analysis & CODIS
  • Rhode Island Department of Health - In-State Analytical Laboratory Certificate
  • Rhode Island Department of Health - In-State Clinical Laboratory License

Clinical Specimen Submission Guidance

Submit all specimens to 50 Orms St, Providence RI 02904. Open Monday to Friday 8:30 AM to 4:30 PM

Disease Chancroid
Reporting Requirement Providers must report patient information on Chancroid within 4 days using the RIDOH reportable disease form.
Disease Clostridium Difficile Infection
Disease Coccidioidomycosis fungal infection (Valley fever)
Reporting Requirement Providers must report patient information on Coccidioidomycosis fungal infection within 4 days using the RIDOH reportable disease form.
Lab Special Pathogens & Biothreats Laboratory 401-222-5586
Pathogen Neisseria gonorrhoeae
Disease Gonococcal Infection (Gonorrhea)
Test Description N. gonorrhoeae
Special Instructions

N. gonorrhoeae is a fastidious organism and is very sensitive to temperature fluctuations.

Refrigerated media must be brought to room temperature before inoculation.

Incubator must remain between 35-37°C.

Culture plates should remain in the incubator until they are transported to the State Health Laboratories.

Specimen

PRIMARY CULTURES ARE ONLY ACCEPTED FROM STATE DESIGNATED CLINICS. Primary specimen taken from rectal or throat (non-urogenital site) and inoculated onto Martin Lewis or Thayer Martin Plate.

Sub plate immediately after specimen collection and incubate within 15 minutes of media inoculation at 35-37° C in CO2 atmosphere.

Isolates for confirmation can be sent on Martin Lewis or Thayer Martin.

Form Required Rhode Island State Health Laboratories test requisition form
Test Request Gonorrhea Culture
Transport

Transport at ambient temperature within 48 hours in bag containing CO2 tablet.

Isolates from Hospitals: All submissions must be properly packaged in accordance with current federal shipping regulations. Containers specifically labeled for transport of specimens and isolates to the HEALTH Molecular amd Enteric Laboratory are available in all microbiology labs and laboratory send out departments.

Reporting Requirement Providers must report patient information on Gonococcal Infection within 4 days using the RIDOH reportable disease form.
Turnaround Time 3 business days
Disease Granuloma inguinale
Reporting Requirement Providers must report patient information on Granuloma inguinale within 4 days using the RIDOH reportable disease form.
Disease Heartwater Disease
Disease Hemolytic Uremic Syndrome (HUS)
Reporting Requirement Providers must report patient information on Hemolytic Uremic Syndrome within 4 days using the RIDOH reportable disease form.
Lab STI & Arbovirus Laboratory 401-222-5591
Pathogen Hepatitis A Virus
Disease Hepatitis A (Hep A)
Test Description Two-step immunoassay for the qualitative detection of IgM anti-HAV in human serum and plasma using CMIA technology
Specimen Minimum 5ml serum or plasma
Form Required Rhode Island State Health Laboratories test requisition form
Test Request Hepatitis A IgM
Transport

Transport as soon a possible. Specimen can be stored at 2° - 8°C for up to one week.

All submissions must be properly packaged in accordance with current federal shipping regulations. Containers specifically labeled for transport of specimens to the HEALTH Serology Laboratory are available in all serology labs and laboratory send out departments.

Integrity Non-hemolyzed
Normal Value Negative
Reporting Requirement Providers must report patient information on Hepatitis A immediately using the RIDOH reportable disease form.
Turnaround Time Routine is up to 2 weeks. STAT testing may be requested by contacting the laboratory directly at (401) 222-5591
Lab STI & Arbovirus Laboratory 401-222-5591
Pathogen Hepatitis B Virus
Disease Hepatitis B (Hep B)
Test Description Two-step immunoassay for the qualitative detection of Hepatitis B antigen and antibodies
Specimen Minimum 5ml serum or plasma
Form Required Rhode Island State Health Laboratories test requisition form
Test Request Hepatitis B Core IgM, Hepatitis B Total Core, Hepatitis B Surface Antibody, Hepatitis B Surface Antigen
Transport

As soon as possible. Specimen can be stored at 2° to 8° C for up to one week.

All submissions must be properly packaged in accordance with current federal shipping regulations. Containers specifically labeled for transport of specimens to the HEALTH Serology Laboratory are available in all serology labs and laboratory send out departments.

Integrity Non-hemolyzed
Normal Value Negative
Reporting Requirement Providers must report patient information on Hepatitis B within 4 days using the RIDOH reportable disease form.
Turnaround Time Routine is up to 2 weeks. STAT testing may be requested by contacting the laboratory directly at (401) 222-5591
Disease Hepatitis D (Hep D)
Reporting Requirement Providers must report patient information on Hepatitis D within 4 days using the RIDOH reportable disease form.
Disease Hepatitis E (Hep E)
Reporting Requirement Providers must report patient information on Hepatitis E within 4 days using the RIDOH reportable disease form.
Pathogen simplex viruses HDV-1, HSV-2
Disease Herpes
Pathogen Histoplasma capsulatum
Disease Histoplasmosis infection (Histoplasmosis)
Disease Human Papillomavirus (HPV)
Disease Leptospirosis
Reporting Requirement Providers must report patient information on Leptospirosis within 4 days using the RIDOH reportable disease form.
Pathogen Borrelia burgdorferi
Disease Lyme Disease
Reporting Requirement Providers must report patient information on Lyme Disease within 4 days using the RIDOH reportable disease form.
Disease Lymphogranuloma venereum infection (LGV)
Reporting Requirement Providers must report patient information on Lymphogranuloma venereum infection within 4 days using the RIDOH reportable disease form.
Disease Meningitis (Meningitis, viral)
Reporting Requirement Providers must report patient information on Meningitis (Viral) within 4 days using the RIDOH reportable disease form.
Lab Special Pathogens & Biothreats Laboratory 401-222-5586
Pathogen Streptococcus pneumoniae
Disease Streptococcus pneumonia disease
Test Description MIC (performed by CDC)
Specimen Only isolates from invasive disease/normally sterile site that are penicillin resistant by oxacillin disk screen and have not had a MIC performed. Submit a freshly growing pure isolate (< 48 hours old) on a chocolate agar slant secured with a screw cap. Isolates on plated media are acceptable if plates are sealed with parafilm or other appropriate barrier film.
Form Required

Rhode Island State Health Laboratories test requisition form

CDC DASH Form

Test Request

Special Pathogens Bacterial Isolate

Write "S. pneumoniae" in comment field of requisition form

Transport All submissions must be properly packaged in accordance with current federal shipping regulations. Containers specifically labeled for transport of specimens and isolates to the HEALTH Bioterrorism Response & Special Pathogens Laboratory are available in all microbiology labs and laboratory send out departments.
Turnaround Time Unknown (testing performed at CDC)
Disease Molluscum Contagioscum Infection (Molluscum Contagioscum)
Disease Nongonococcal Urethritis (NGU)
Disease Bed Bugs
Disease Cytauxzoonis
Disease Clostridium Perfringens (Epsilon Toxin)
Reporting Requirement Providers must report patient information on Clostridium Perfringens immediately using the RIDOH reportable disease form.
Disease Meningitis
Reporting Requirement Providers must report patient information on Meningitis immediately using the RIDOH reportable disease form.
Lab Special Pathogens & Biothreats Laboratory 401-222-5586
Disease Ornithosis
Test Description Preauthorization from the HEALTH Division of Infectious Disease and Epidemiology is required (401) 222-2577. If testing is approved, specimens are sent from the HEALTH Special Pathogens Laboratory to the CDC for testing.
Specimen Consult with the HEALTH Special Pathogens Lab at (401) 222-5586 for guidance on specimen selection, collection and submission.
Form Required Rhode Island State Health Laboratories test requisition form
Test Request CDC Sendout
Transport All submissions must be properly packaged in accordance with current federal shipping regulations. Containers specifically labeled for transport of specimens and isolates to the HEALTH Bioterrorism Response & Special Pathogens Laboratory are available in all microbiology labs and laboratory send out departments.
Reporting Requirement Providers must report patient information on Ornithosis within 4 days using the RIDOH reportable disease form.
Turnaround Time Unknown (testing performed by CDC)
Disease Paralytic Shellfish Poisoning (Paralytic Shellfish Poisoning, Ciguatera)
Reporting Requirement Providers must report patient information on Paralytic Shellfish Poisoning immediately using the RIDOH reportable disease form.
Pathogen Pediculosa capitis and corporis
Disease Pediculosis (Lice, Head and Body Lice)
Disease Pelvic Inflammatory Disease (PID)
Reporting Requirement Providers must report patient information on Pelvic Inflammatory Disease within 4 days using the RIDOH reportable disease form.
Disease Pneumococcal Disease (Pneumonia)
Reporting Requirement Providers must report patient information on Pneumococcal Disease within 4 days using the RIDOH reportable disease form.
Disease Poliomyelitis (Polio)
Reporting Requirement Providers must report patient information on Poliomyelitis immediately using the RIDOH reportable disease form.
Disease Encephalitis
Reporting Requirement Providers must report patient information on Encephalitis (Arboviral or parainfectious) immediately using the RIDOH reportable disease form.
Pathogen Phthirus pubis
Disease Pthiriasis (Crabs; Pubic Lice Infestation)
Disease Ricin Poisoning
Reporting Requirement Providers must report patient information on Ricin Poisoning immediately using the RIDOH reportable disease form.
Disease Rotovirus (Rotavirus)
Pathogen Scabies hominis
Disease Scabies Infestation (Scabies)
Disease Scombroid
Reporting Requirement Providers must report patient information on Scombroid immediately using the RIDOH reportable disease form.
Disease Severe Acute Respiratory Syndrome (SARS)
Disease Smallpox
Reporting Requirement Providers must report patient information on Smallpox immediately using the RIDOH reportable disease form.
Disease Staphyloccal Infection (MRSA)
Disease Staphylococcal Food Poisoning (Staph Food Poisoning)
Reporting Requirement Providers must report patient information on Staphylococcal Food Poisoning (Enterotoxin - B Poisoning) immediately using the RIDOH reportable disease form.
Pathogen Staphylococcus aureus,Vancomycin Intermediate
Disease Staphylococcal Infection (VISA)
Reporting Requirement Providers must report patient information on Staphylococcal Infection (Vancomycin Intermediate) immediately using the RIDOH reportable disease form.
Disease Streptococcal Disease (Strep-B)
Reporting Requirement Providers must report patient information on Streptococcal Disease (Group B) within 4 days using the RIDOH reportable disease form.
Disease Streptococcal Toxic-Shock Syndrome (STSS, TSS)
Reporting Requirement Providers must report patient information on Streptococcal Toxic-Shock Syndrome (STSS, Toxic Shock) within 4 days using the RIDOH reportable disease form.
Disease Tetanus Infection (Lock Jaw)
Reporting Requirement Providers must report patient information on Tetanus Infection (tetani) within 4 days using the RIDOH reportable disease form.
Pathogen Trichinella spiralis
Disease Trichonosis Infection (Trichinosis)
Reporting Requirement Providers must report patient information on Trichonosis Infection within 4 days using the RIDOH reportable disease form.
Disease Vaginosis (Yeast Infection)
Disease Varicella (Chickenpox)
Reporting Requirement Providers must report patient information on Varicella within 4 days using the RIDOH reportable disease form.
Pathogen EV-D68
Disease Enterovirus Infection (EV-D68)
Disease Yellow Fever
Reporting Requirement Providers must report patient information on Yellow Fever immediately using the RIDOH reportable disease form.
Disease Herpes Zoster (Shingles)
Lab STI & Arbovirus Laboratory 401-222-5591
Disease COVID-19 (Coronavirus Disease 2019)
Test Description

TEST CURRENTLY NOT PERFOMED AT THE RISHL

The Abbott Laboratories SARS-CoV-2 IgG serological test is an immunoassay for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma using chemiluminescent microparticle immunoassay (CMIA) technology.

The Abbott Laboratories SARS-CoV-2 IgG assay is only for use under a Food and Drug Administration Emergency Use Authorization. The performance characteristics of this assay were validated by the Rhode Island State Health Laboratories (RISHL).

Results should be used in conjunction with the patient's clinical symptoms, medical history, and other clinical/laboratory findings to determine an overall clinical diagnosis. Results should not be used to infer an immunity status nor predict resistance or susceptibility to a future exposure to SARS-CoV-2.

Provider Fact Sheet: https://www.fda.gov/media/137381/download

Patient Fact Sheet: https:www.fda.gov/media/137382/download

Special Instructions

PREAUTHORIZATION by the Rhode Island Department of Health (RIDOH) Center for Acute Infectious Disease Epidemiology at (401)222-3577 is required prior to transport.

Specimen

Collect minimum 3 mL serum or plasma or 5 mL whole blood in EDTA or heparin tube

Refrigerate at 2 ° - 8°C. Stable for one week following centrifugation.

Collected specimens are delivered to the Rhode Island State Health Laboratories (RISHL) for SARS-CoV-2 testing.

CLIA regulations require two patient identifiers on the specimen container and the test requisition.

Form Required

Rhode Island State Health Laboratories (RISHL) test requisition form https://health.ri.gov/forms/LabRequisitionForm.pdf

Test Request

COVID-19 Serology

Transport

Specimens must be transported in accordance with current federal shipping regulations.

PREATHORIZATION is required prior to sending specimens.

Integrity

Non-hemolyzed

Normal Value

Negative

Reporting Requirement Providers must report patient information on COVID-19 immediately using the RIDOH reportable disease form.
Turnaround Time

Testing at Rhode Island State Health Laboratories completed within 3 business days from specimen receipt